Trial Profile
A study investigating the effects on glucose metabolism of conversion from tacrolimus twice-daily (BID) to tacrolimus once-daily in stable kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Pharmacodynamics
- 06 Dec 2015 New trial record